X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1936) 1936
Conference Proceeding (504) 504
Publication (126) 126
Book Chapter (12) 12
Book Review (11) 11
Book / eBook (2) 2
Newsletter (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1001) 1001
gastroenterology & hepatology (688) 688
index medicus (583) 583
male (547) 547
female (530) 530
adult (450) 450
middle aged (442) 442
aged (278) 278
animals (193) 193
liver (183) 183
medicine, general & internal (179) 179
hepatitis (172) 172
hepatitis c (171) 171
transplantation (146) 146
therapy (145) 145
immunology (143) 143
liver transplantation (141) 141
mice (139) 139
treatment outcome (138) 138
hepatitis c virus (131) 131
infection (131) 131
antiviral agents - therapeutic use (130) 130
health aspects (130) 130
adolescent (123) 123
cirrhosis (117) 117
disease (114) 114
expression (114) 114
surgery (110) 110
gastroenterology and hepatology (106) 106
care and treatment (105) 105
infectious diseases (100) 100
risk factors (99) 99
liver cirrhosis (97) 97
hepatitis c, chronic - drug therapy (96) 96
analysis (95) 95
chronic active hepatitis (95) 95
research (92) 92
virology (89) 89
interferon (84) 84
liver diseases (84) 84
retrospective studies (82) 82
hepatology (81) 81
ribavirin (81) 81
diagnosis (80) 80
cancer (79) 79
infections (79) 79
drug therapy, combination (78) 78
prognosis (77) 77
time factors (76) 76
young adult (75) 75
abridged index medicus (74) 74
hepacivirus - genetics (73) 73
hepatocellular-carcinoma (72) 72
interferon-alpha - therapeutic use (72) 72
genotype (71) 71
follow-up studies (70) 70
liver - pathology (70) 70
prospective studies (70) 70
virus-infection (70) 70
aged, 80 and over (68) 68
patients (67) 67
hepatitis b (66) 66
prevalence (64) 64
mortality (63) 63
management (62) 62
germany (60) 60
hepatocellular carcinoma (60) 60
recurrence (60) 60
antibodies (59) 59
medical colleges (58) 58
cells, cultured (57) 57
fibrosis (56) 56
gastroenterology (56) 56
ribavirin - therapeutic use (56) 56
chronic disease (54) 54
pharmacology & pharmacy (53) 53
rna (53) 53
survival (53) 53
biochemistry & molecular biology (52) 52
virus diseases (52) 52
apoptosis (51) 51
autoantibodies (51) 51
autoimmune hepatitis (51) 51
cell biology (50) 50
cells (50) 50
child (50) 50
viruses (50) 50
biopsy (49) 49
medicine (49) 49
natural-history (49) 49
liver-transplantation (48) 48
oncology (48) 48
primary biliary-cirrhosis (48) 48
antiviral agents - administration & dosage (46) 46
gene expression (46) 46
genetic aspects (46) 46
medical research (46) 46
medicine, research & experimental (46) 46
recombinant proteins (46) 46
antigens (45) 45
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gastroenterology, ISSN 0016-5085, 2015, Volume 148, Issue 1, pp. 108 - 117
Background & Aims Interferon alfa–based regimens used to treat recurrent hepatitis C virus (HCV) infection after liver transplantation are poorly tolerated,... 
Gastroenterology and Hepatology | Antiviral Agent | Clinical Trial | DAA | NS5B Polymerase Inhibitor | PLUS RIBAVIRIN | ANTIVIRAL THERAPY | EFFICACY | HCV GENOTYPE 1 | MULTICENTER EXPERIENCE | COMBINATION | RECIPIENTS | PEGYLATED INTERFERON | GRAFT-SURVIVAL | GASTROENTEROLOGY & HEPATOLOGY | DRUG-DRUG INTERACTIONS | Recurrence | Prospective Studies | Antiviral Agents - pharmacokinetics | Hepatitis C - drug therapy | Liver Transplantation - adverse effects | United States | Humans | Drug Resistance, Viral | Hepacivirus - genetics | Hepacivirus - pathogenicity | Male | RNA, Viral - blood | Viral Load | Time Factors | Ribavirin - pharmacokinetics | Female | Hepatitis C - complications | Uridine Monophosphate - adverse effects | Drug Therapy, Combination | Uridine Monophosphate - therapeutic use | Hepacivirus - drug effects | Liver Neoplasms - virology | Liver Cirrhosis - diagnosis | Antiviral Agents - therapeutic use | Carcinoma, Hepatocellular - diagnosis | Ribavirin - therapeutic use | Carcinoma, Hepatocellular - surgery | Genotype | Liver Neoplasms - surgery | Treatment Outcome | Carcinoma, Hepatocellular - virology | Biomarkers - blood | Spain | New Zealand | Hepatitis C - diagnosis | Pilot Projects | Liver Cirrhosis - virology | Liver Neoplasms - diagnosis | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Uridine Monophosphate - analogs & derivatives | Liver Cirrhosis - surgery | Uridine Monophosphate - pharmacokinetics | Sofosbuvir | Virus diseases | Relapse | Liver | Transplantation | Biological response modifiers | Drug therapy | Hepatitis C virus | Health aspects | Immunosuppressive agents | Ribavirin | Diseases
Journal Article
Journal of Hepatology, ISSN 0168-8278, 05/2018, Volume 68, Issue 5, pp. 878 - 880
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2017, Volume 376, Issue 22, pp. 2134 - 2146
Journal Article
Gastroenterology, ISSN 0016-5085, 2015, Volume 149, Issue 6, pp. 1345 - 1360
Chronic hepatitis C virus (HCV) infection is associated with several extrahepatic manifestations. Patients with HCV may develop mixed cryoglobulinemia and its... 
Gastroenterology and Hepatology | Fatigue | Cryoglobulins | Cardiovascular Risk | Health-Related Quality of Life | Insulin Resistance | PORPHYRIA-CUTANEA-TARDA | MIXED CRYOGLOBULINEMIA VASCULITIS | PATIENT-REPORTED OUTCOMES | SUSTAINED VIROLOGICAL RESPONSE | MAGNETIC-RESONANCE-SPECTROSCOPY | POPULATION-BASED COHORT | ALPHA-2A PLUS RIBAVIRIN | QUALITY-OF-LIFE | CHRONIC HCV INFECTION | IDIOPATHIC PULMONARY-FIBROSIS | GASTROENTEROLOGY & HEPATOLOGY | Interferon-alpha - pharmacology | Vasculitis - epidemiology | Humans | Hepatitis C, Chronic - virology | Hepacivirus - pathogenicity | Vasculitis - virology | Cryoglobulinemia - virology | Hepatitis C, Chronic - mortality | Cryoglobulinemia - epidemiology | Glucose Metabolism Disorders - virology | Hepatitis C, Chronic - epidemiology | Glomerulonephritis - epidemiology | Hepacivirus - drug effects | Lymphoma - epidemiology | Antiviral Agents - pharmacology | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Glomerulonephritis - virology | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Morbidity | Hepatitis C, Chronic - immunology | Glucose Metabolism Disorders - epidemiology | Ribavirin - pharmacology | Lymphoma - virology | Medical colleges | Patient outcomes | Liver | Mortality | Atherosclerosis | Insulin resistance | Lymphomas | Hepatitis C | Biological response modifiers | Hepatitis C virus
Journal Article